Lysyl oxidases related to human diseases

Progress in Biochemistry and Biophysics

Volumn 38, Issue 5, 2011, Pages 389-399

  Zhang, Yan Jun ^a   Jiang, Jia Huan ^a   Xie, Jing ^a   Yang, Li ^a   Sung Kl, Paul ^a,b  

^a CHONGQING UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extra cellular matrix; Lysyl oxidase; Matrix crosslink; Remodeling; Tissue healing

Indexed keywords

EID: 79960268281     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00468     Document Type: Review

References (46)

1. Lucero H A, Kagan H M. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci, 2006, 63(19-20): 2304-2316 (Pubitemid 44653041)
2. Saad F A, Torres M, Wang H, et al. Intracellular lysyl oxidase: Effect of a specific inhibitor on nuclear mass in proliferating cells. Biochem Biophys Res Commun, 2010, 396(4): 944-949
3. Uzel M I, Scott I C, Babakhanlou-Chase H, et al. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J Biol Chem, 2001, 276(25): 22537-22543
4. Fogelgren B, Polgór N, Szauter K M, et al. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem, 2005, 280(26): 24690-24697 (Pubitemid 40934558)
5. Ben Q W. Cancer Research on Prevention and Treatment, 2009, 36(5): 440-442
6. Maruhashi T, Kii I, Saito M, et al. Interaction between periostin and bmp-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem, 2010, 285(17): 13294-13303
7. Thomassin L, Werneck C C, Broekelmann T J, et al. The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers. J Biol Chem, 2005, 280(52): 42848-42855 (Pubitemid 43049247)
8. Vora S R, Guo Y, Stephens D N, et al. Characterization of recombinant lysyl oxidase propeptide. Biochem, 2010, 49(13): 2962-2972
9. Guo Y, Pischon N, Palamakumbura A H, et al. Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells. J Am Physiol Cell Physiol, 2007, 292(6): 2095-2102
10. Horiguchi M, Inoue T, Ohbayashi T, et al. Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase. Proc Natl Acad Sci USA, 2009, 106(45): 19029-19034
11. Palamakumbura A H, Jeay S, Guo Y, et al. The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem, 2004, 279(39): 40593-40600 (Pubitemid 39287651)
12. Palamakumbura A H, Vora, S R, Nugent M A, et al. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene, 2009, 28 (38): 3390-3400
13. Hurtado P A, Vora S, Sume S S, et al. Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem Biophys Res Commun, 2008, 366(1): 156-161 (Pubitemid 50008466)
14. Ryvkin F, Greenaway F T. A peptide model of the copper-binding region of lysyl oxidase. J Inorg Biochem, 2004, 98(8): 1427-1435 (Pubitemid 38951063)
15. Hornstra I K, Birge S, Starcher B, et al. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem, 2003, 278(16): 14387-14393 (Pubitemid 36799990)
16. Mäki J M, Sormunen R, Lippo S, et al. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. J Am Pathol, 2005, 167(4): 927-936 (Pubitemid 41416246)
17. Gansner J M, Mendelsohn B A, Hultman K A, et al. Essential role of lysyl oxidases in notochord development. Dev Biol, 2007, 307(2): 202-213 (Pubitemid 47001354)
18. Reynaud C, Baas D, Gleyzal C, et al. Morpholino knockdown of lysyl oxidase impairs zebrafish development, and reflects some aspects of copper metabolism disorders. Matrix Biol, 2008, 27 (6): 547-560
19. Szauter K M, Cao T Y, Boyd C D, et al. Lysyl oxidase in development, aging and pathologies of the skin. Pathol Biol, 2005, 53(7): 448-456 (Pubitemid 41112081)
20. Hou Y, Mao Z B, Wei X L, et al. The roles of TGF-beta1 gene transfer on collagen formation during Achilles tendon healing. Biochem Biophys Res Commun, 2009, 383(2): 235-239
21. Ordas A, Szauter K M, Fogelgren B, et al. Lysyl oxidase and fibulin-1 interactions in scleroderma. Matrix Biol, 2006, 25(Supplement 1): 37
22. Layman D L, Sampath Narayanan A, Martin G R. The production of lysyl oxidase by human fibroblasts in culture. Arch Biochem Biophys, 1972, 149(1): 97-101
23. Hayashi H, Gotoh N, Uedo Y, et al. Lysyl Oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. J Am Ophthalmol, 2008, 145(3): 582-585
24. Pasutto F, Krumbiegel M, Mardin C Y, et al. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophth Vis Sci, 2008, 49(4): 1459-1463
25. Sharma S, Chataway T, Burdon K P, et al. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res, 2009, 89(4): 479-485
26. Schlötzer-Schrehardt U. Molecular pathology of pseudoexfoliation syndrome/glaucoma - new insights from LOXL1 gene associations. Exp Eye Res, 2009, 88(4): 776-785
27. Price D J, Ravindranath T, Kaler S G, et al. Internal jugular phlebectasia in Menkes disease. J Int of Pediatr Otorhi, 2007, 71(7): 1145-1148 (Pubitemid 46783038)
28. Vadasz Z, Kessler O, Akiri G, et al. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. J Hepatol, 2005, 43(3): 499-507 (Pubitemid 41111433)
29. Zhao Y Z, Chen L J, Gao S, et al. The critical role of the cellular thiol homeostasis in cadmium perturbation of the lung extracellular matrix. Toxicology, 2010, 267(1-3): 60-69
30. Alperin M, Debes K, Abramowitch S, et al. LOXL1 deficiency negatively impacts the biomechanical p roperties of the mouse vagina and supportive tissues. J Int Urogynecol, 2008, 19(7): 977-986 (Pubitemid 351772632)
31. Jung H J, Jeon M J, Yim G W, et al. Changes in expression of fibulin-5 and lysyl oxidase-like1 associated with pelvic organ prolapse. J Eur Obstet Gynecol Reprod Biol, 2009, 145(1):117-122
32. Klutke J, Stanczyk F Z, Ji Q, et al. Suppression of lysyl oxidase gene expression by methylation in pelvic organ prolapse. J Int Urogynecol Pelvic Floor Dysfunct, 2010, 21(7): 869-872
33. Oxlund H, Barckman M, Ortoft G, et al. Reduced concentration of collagen cross-links are associated with reduced strength of bone. Bone, 1995, 17(4 Suppl): 365-371
34. Saito M, Shiraishi A, Ito M, et al. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone, 2010, 46(4): 1170-1179
35. 3 regulates collagen quality in an osteoblastic cell culture system. Biochem Biophys Res Commun, 2008, 377(2): 674-678
36. Rodrlguez C, Alcudia J F, Martlnez-González J, et al. Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction. Atherosclerosis, 2008, 196(2): 558-564
37. Rodriguez C, Alcudia J F, Martinez-Gonzalez J, et al. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors. Cardiovasc Res, 2009, 83(3): 595-603
38. Gilad G M, Kagan H M, Gilad V H. Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci Lett, 2005, 376(3): 210-214 (Pubitemid 40255311)
39. Mulligan V K, Kerman A, Ho S, et al. Denaturational stress induces formation of zinc-deficient monomers of Cu, Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis. J Mol Biol, 2008, 383(2): 424-436
40. Li P A, He Q P, Cao T Y, et al. Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res Mol Brain Res, 2004, 120(2): 115-122
41. Rückert F, Joensson P, Saeger H D, et al. Functional analysis of LOXL2 in pancreatic carcinoma. J Int Colorectal Dis, 2010, 25(3): 303-311
42. Denko N C, Fontana L A, Hudson K M, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene, 2003, 22(37): 5907-5914 (Pubitemid 37176711)
43. Santhanam A N, Baker A R, Hegamyer G. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene, 2010, 29(27): 3921-3932
44. Contente S, Kenyon K, Sriraman P, et al. Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene. Mol Cell Biochem, 1999, 194(1-2): 79-91 (Pubitemid 29245546)
45. Contente S, Yeh T J, Friedman R M. Tumor suppressive effect of lysyl oxidase proenzyme. Biochim Biophys Acta, 2009, 1793(7): 1272-1278
46. Sakai M, Kato H, Sano A, et al. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol, 2009, 16(9): 2494-2501